Physician profile
Niraj Patel
NPI 1831101336
$2,827.57
in general payments reported to CMS, 2019-2025
29 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $87.66 · 2021: $455 · 2022: $492 · 2023: $551 · 2024: $435 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Education: $99.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.19 |
| Education | $99.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $812.37 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $281.93 | 2021-2024 | |
| Astellas Pharma US INC | $258.57 | 2022-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $234.54 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $192.16 | 2023-2025 | Myfembree |
| Exact Sciences Corporation | $150.08 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $100.84 | 2022-2024 | |
| Lupin INC. | $73.51 | 2019-2020 | |
| Hologic Sales and Service, LLC | $72.99 | 2019-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Bayer Healthcare Pharmaceuticals INC. | $72.90 | 2019-2023 | |
| Exeltis, USA INC. | $61.98 | 2024 | Slynd |
| Shield Therapeutics INC | $61.92 | 2023-2024 | Accrufer |
| Smith+Nephew, INC. | $59.90 | 2021-2023 | Stravix Pl |
| Millicent US INC | $55.71 | 2024-2025 | Femlyv |
| Agile Therapeutics, INC. | $46.25 | 2023-2024 | Twirla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $45.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $33.86 | 2019 | |
| Ethicon US, LLC | $27.41 | 2019 | |
| Gynesonics, INC. | $24.20 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sage Therapeutics, LLC | $22.19 | 2024 | |
| Organon LLC | $19.92 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $19.39 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $18.99 | 2019 | |
| Dexcom, INC. | $18.54 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $18.32 | 2022 | |
| Amgen INC. | $17.66 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.62 | 2019 | |
| Coopersurgical, INC. | $12.39 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.